Welcome to New Frontiers in Structure - Based Drug Discovery

 

 

Extended deadline for abstract submission 15.07.2019!

 

The Marie Skłodowska - Curie European Training Networks AEGIS and TASPPI are pleased to announce the common organized international conference New Frontiers in Structure-Based Drug Discovery, Sep 23-25, 2019 at Convitto della Calza in Florence, Italy.

Attracting a high-level audience of researchers, the conference will provide a stimulating platform to discuss with academic experts and scientists from biotech and pharmaceutical industries. Topics include innovative screens on protein-protein interactions, novel targets and target validation, structure-based drug discovery, computational approaches and more. The conference will provide a valuable platform to discuss the challenges and opportunities of modern drug discovery in academia and industry.

Already since the times of Leonardo da Vinci, Florence provides with his vibrating scientific and cultural environment  an excellent framework for the valuable experience of collaboration and scientific exchange reaching out to junior investigators and leading scientists in the field of drug research.

In order to foster interaction and discussions in the field, we are pleased to host an exceptional group of internationally renowned experts on the topic of drug discovery, who build the framework of the New Frontiers in Structure-based Drug Discovery's scientific program.

Additional oral presentations will be selected from submitted abstracts at New Frontiers in Structure-Based Drug Discovery.
A poster session will provide opportunities for further discussions.

 

Registration deadline:    July 31, 2019                          Deadline for abstracts:    June 30, 2019

 

Speakers (confirmed):

Patrizia

Aducci 

Università di Roma

Italy

Michelle                

Arkin

University of California San Francisco                                

United States

Alessio

Ciulli

University of Dundee

United Kingdom

Steve

Fesik

Vanderbilt University  

United States                          

Mike

Hann

GlaxoSmithKline 

United Kingdom

Birthe

Kragelund                       

University of Copenhagen

Denmark

Ora Schueler-Furman Hebrew University Israel

Jan

Steyaert

VIB

Belgium

Ed

Tate

Imperial College London   

United Kingdom

Rebecca

Wade

HITS gGmbH, Heidelberg University 

Germany

 

Organization Committee:

Michael Sattler, Eva Schlosser (both Helmholtz Zentrum München), Christian Ottmann (University of Eindhoven), Michael Nilges (Institut Pasteur), Gerhard Klebe (Philipps-Universität Marburg), Wolfgang Jahnke (Novartis), Alex Dömling (University of Groningen),  Matteo Gentili and Laura Bassani (both Giotto Biotech)

 

The conference New Frontiers in Structure-based Drug Discovery as well as the programs AEGIS and TASPPI are funded by the EU Horizon 2020 (2014–2020) framework program under the Marie Skłodowska-Curie Grant Agreement no. 675555, AEGIS and Grant Agreement no. 675179, TASPPI.

Gold Sponsors

 

Silver Sponsors

Bronze Sponsors

Exhibitor

We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.